Bildkälla: Stockfoto

Medivir: Lenvima arm fully recruited - Redeye

Redeye comments on the inclusion of the last patient in the Lenvima arm of the phase IIa trial of fostrox in advanced liver cancer.

Redeye comments on the inclusion of the last patient in the Lenvima arm of the phase IIa trial of fostrox in advanced liver cancer.
Börsvärldens nyhetsbrev
ANNONSER